NW
COLL icon

NewEdge Wealth’s Collegium Pharmaceutical COLL Stock Holding History

NewEdge Wealth’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Buy
48,989
+10,096
+26% +$345K 0.02% 493
2026
Q1 		$1.29M Buy
38,893
+14,529
+60% +$615K 0.02% 554
2025
Q4 		$1.13M Buy
24,364
+2,585
+12% +$108K 0.01% 591
2025
Q3 		$781K Buy
21,779
+4,237
+24% +$147K 0.01% 624
2025
Q2 		$578K Buy
17,542
+2,227
+15% +$63.5K 0.01% 672
2025
Q1 		$457K Buy
15,315
+2,608
+21% +$79.7K 0.01% 677
2024
Q4 		$364K Buy
+12,707
New +$420K 0.01% 716

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

NewEdge Wealth's COLL Position: Q2 2026 in Review

NewEdge Wealth increased its Collegium Pharmaceutical (COLL) stake by 26% in Q2 2026, buying an estimated $345K and bringing the position to 48,989 shares worth $1.77M. The position accounts for 0.02% of the portfolio, ranked #493.

NewEdge Wealth first reported a position in COLL in Q4 2024 and has held it in 7 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • NewEdge Wealth held 48,989 shares of Collegium Pharmaceutical worth $1.77M as of Q2 2026.
  • NewEdge Wealth bought 10,096 Collegium Pharmaceutical shares in Q2 2026, an estimated $345K.
  • Collegium Pharmaceutical made up 0.02% of NewEdge Wealth's portfolio in Q2 2026, its #493 holding.
  • NewEdge Wealth first reported a position in Collegium Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.